ArticleTechnical innovations & patient support in radiation oncology2025
Insights from initial experience for nasopharyngeal carcinoma patients treated with proton therapy.
Article in Technical innovations & patient support in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiotherapy is the cornerstone for the treatment of nasopharyngeal carcinoma (NPC). Due to its unique epidemiology and the location of the disease with neighbouring critical structures, conventional photon irradiation may result in significant long-term morbidities in patients. With increasing numbers of proton beam therapy (PBT) centres worldwide, patients with NPC now have an alternative option of irradiation that potentially gives equivalent disease control, yet significantly reduces the acute and long-term toxicities. The proper adoption of PBT in NPC requires a series of intricate procedures: pre-treatment preparation, treatment planning, advanced image verification and adaptive PBT. Each process is crucial to allow the proton beam deposit precise dose in Bragg peak's region, resulting in optimal planned target volume coverage while allowing maximum sparing of adjacent dose-limiting organs. Therefore, comprehensive protocols for these coordinated procedures have been developed at our centre to achieve optimal outcomes for patients with NPC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.